Patent Assignment
Reel/Frame 044694/0982
Assignment of Assignor's Interest
Recorded: 2018-01-23
Pages: 16
Assignors
CHEN, WEIRONG
Executed: 2008-07-10
FRANKLIN, LLOYD
Executed: 2008-07-10
GUAN, BING
Executed: 2008-07-10
JONES, JOHN HOWARD
Executed: 2008-07-10
KUMARAVEL, GNANASAMBANDAM
Executed: 2008-07-10
LANE, BENJAMIN
Executed: 2008-07-10
LITTKE, ADAM
Executed: 2008-07-10
LUGOVSKOY, ALEXEY
Executed: 2008-07-10
PENG, HAIRUO
Executed: 2008-07-10
POWELL, NOEL
Executed: 2008-07-10
VESSELS, JEFFREY
Executed: 2008-07-10
WYNN, THOMAS
Executed: 2008-07-10
XIN, ZHILI
Executed: 2008-07-10
Assignee
BIOGEN IDEC MA INC.
14 CAMBRIDGE CENTER, CAMBRIDGE, MASSACHUSETTS, 02142
Covered Property
(1)
Substituted Pyrimidines for Inhibiting Raf Kinase Activity
Related Assignments
(7)
Other recorded transfers of the patent in this record — the chain of ownership.
Assignment of Assignor's Interest
Jan 23, 2018
From: COSSROW, JENNIFER; RAIMUNDO, BRIAN C.; TANAKA, HIROKO
To: SUNESIS PHARMACEUTICALS, INC.
Reel/Frame 044695/0001 →
Assignment of Assignor's Interest
Jan 23, 2018
From: BIOGEN IDEC MA INC.
To: MILLENNIUM PHARMACEUTICALS, INC.
Reel/Frame 044695/0020 →
Assignment of Assignor's Interest
Jan 14, 2021
From: MILLENNIUM PHARMACEUTICALS, INC.
To: DOT THERAPEUTICS-1, INC.
Reel/Frame 054921/0546 →
Merger
May 17, 2022
From: DOT THERAPEUTICS-2, INC.; DOT THERAPEUTICS-1, INC.
To: DAY ONE BIOPHARMACEUTICALS, INC.
Reel/Frame 059936/0096 →
Change of Name
Apr 14, 2023
From: SUNESIS PHARMACEUTICALS, INC.
To: VIRACTA THERAPEUTICS, INC.
Reel/Frame 063349/0100 →
Assignment of Assignor's Interest
Dec 3, 2024
From: VIRACTA THERAPEUTICS, INC.
To: XOMA (US) LLC
Reel/Frame 069474/0049 →
Security Interest
Jul 14, 2026
From: CYDEX PHARMACEUTICALS, INC.; LIGAND PHARMACEUTICALS INCORPORATED; METABASIS THERAPEUTICS, INC.; XOMA (US) LLC
To: CITIBANK, N.A., AS ADMINISTRATIVE AGENT
Reel/Frame 075969/0966 →